ICON  Overview
ICON  Mission and Vision
ICON  NoroBio Standard
ICON  Our Culture/Values
ICON  Drug Registration
ICON  Marketing & promotion
ICON  GO & NGO Tender
ICON Finished Medicine
ICON Medical Products
ICON Food supplement
ICON Excipient
ICON Packing Material
ICON  Meet us in CPHI
Betterway
English |  Français  |   Email
SWITCH TO VETERINARY
Home > Products > Finished Medicine > Tablets & Capsules
   - Finished Medicine
  - Tablets & Capsules
  - Powder for injection
  - Others
  - Injections
  - Bio Products
   + Medical Products
   + Food supplement
   + Excipient
   + Packing Material
 
 
 Amodiaquine + Artesunate Tablet 300mg+100mg (Amodiaquine + Artesunate Tablet 300mg+100mg)  
 
General Information:
Artesunate Amodiaquine is a potential combination manufactured for inhibiting intensification of drug resistance and for decreasing malaria transmission levels. Artesunate and amodiaquine tablets are an antimalarial agent. Artesunate is ideal for the treatment of uncomplicated cases of malaria due to Plasmodium falciparum malaria, including cerebral malaria, and amodiaquine is a 4-aminoquinoline compound related to chloroquine used as an antimalarial and anti-inflammatory agent.
Side Effects:
As with all pharmaceuticals, some unwanted effects can occur from the use of artesunate + amodiaquine tablets. Always consult a doctor or health care professional for medical advice before use. Common side effects include, but may not be limited to diarrhea, skin rash, itching, and nausea. Seek medical attention if the following develop: irregular heart beating, diplopia, dizziness.
For a comprehensive list of all possible effects, consult your doctor.
If any symptom persists or gets worse, or you notice any other symptom, then please call your doctor immediately.

Contra-indications, adverse effects, precautions:
– Do not administer in the event of previous severe adverse reaction to treatment with amodiaquine (e.g. hypersensitivity reaction, hepatitis, leucopenia, agranulocytosis).

– Do not administer to patients taking efavirenz.

– May cause: gastrointestinal disturbances, headache, dizziness, pruritus.

– If the patient vomits within 30 minutes after administration, re-administer the full dose.

– Pregnancy: no contra-indication

– Breast-feeding: no contra-indication

© 2010 Noro Bio-Pharmaceutical Co., Ltd. all rights reservedExport Company